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Nanoconstructs, such as liposomes, poly-
meric micelles, gold nanoparticles, carbon 
nanomaterials and nanocrystalline quan-
tum dots, have been widely investigated 
for diagnostic, bioimaging and therapeutic 
applications [1]. Nanoconstructs have been 
also extensively explored in the field of der-
matology. For example, liposomes and poly-
meric nanoparticles loaded with drugs were 
applied as topical administration agents for 
the treatment of skin diseases such as psoria-
sis, dermatitis and skin cancer [2,3]. Titanium 
dioxide and zinc oxide (ZnO) nanoparticles 
have been used as sun-screen formulation 
for the protection of skin from UV by the 
scattering, absorption and reflection of UV 
[4]. Silver nanoparticles are commercially 
used as wound and burn dressing agents 
with antibacterial effects [5]. Quantum dots 
and ZnO nanoparticles were utilized as bio-
imaging agents for the diagnosis of skin dis-
eases [6,7]. Moreover, gold nanoconstructs 
and carbon nanomaterials have been actively 
investigated as promising agents for the pho-
tothermal ablation therapy of skin cancers 
due to their high light-to-heat conversion 
capability [8,9].
For further applications of nanocon-
structs in dermatology, we need efficient 
transdermal delivery carriers of the nano-
constructs. The transdermal delivery has 
several advantages over other administra-
tion routes, such as oral delivery and needle 
based injection. The advantages include 
noninvasive treatment, self-administration, 
improved patient compliance and avoidance 
of hepatic first-pass metabolism or digestion 
system [10]. Despite these benefits, the low 
skin permeability of nanoconstructs such as 
polymers, proteins, hydrophilic drugs and 
nanoparticles limited their wide applications 
to the transdermal delivery. To facilitate the 
transdermal delivery of nanoconstructs, 
additional treatments have been adopted 
using penetration enhancers, iontophoresis, 
ultrasound and microneedles [11]. However, 
these methods require physical perturba-
tions to the skin tissue, causing skin damage 
in some cases [12]. A noninvasive molecular 
carrier for transdermal delivery would have 
compelling advantages. The understand-
ing for the characteristics of skin layers 
can be a good starting point for the devel-
opment of transdermal delivery carriers of 
 nanoconstructs.
Stratum corneum (SC), the outermost 
skin layer, is the main barrier composed of 
densely packed dead cells forming hydro-
phobic surfaces. For the penetration of 
hydrophobic SC, hydrophobic molecules 
have clear benefits over hydrophilic mole-
cules. The hydrophobic molecules can infil-
trate into densely packed lipid layers in SC. 
However, nanoconstructs are usually formu-
lated to have hydrophilic surfaces enhancing 
the physiological stability in the biological 
conditions. This contradicting requirement 
of hydrophobicity and hydrophilicity for 
transdermal delivery should be reconciled to 
enhance the physiological stability and the 
skin permeability by lipid disruption in SC.
Recently, hyaluronic acid (HA) has been 
investigated as a promising transdermal 
delivery carrier. HA is a naturally occurring 
linear polysaccharide composed of repeating 
units of d-glucuronic acid and N-acetyl-
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d-glucosamine. HA is abundant in the epithelial, con-
nective and neural tissues. HA is biocompatible, bio-
degradable, nonimmunogenic and nontoxic. HA has 
been regarded as one of the best biopolymers for bio-
medical applications including drug delivery and tis-
sue engineering. HA is one of the major components 
in the skin and plays an important role in extracellular 
matrix. HA also participates in tissue hydrodynam-
ics, cell movement and proliferation, and interactions 
with a variety of cells with HA receptors like CD44 
and RHAMM. Furthermore, HA is viscoelastic and 
hygroscopic enabling cosmetic and cosmeceutical 
applications. Brown et al. reported that radiolabeled 
HA with a high molecular weight of 360–400 kDa 
could pass through SC, epidermis and dermis layers 
of mouse and human skins [13]. Interestingly, high-
molecular-weight HA was reported to inhibit the 
malignant tumor progression [14]. The antitumor 
effect of HA can contribute to the treatment of skin 
cancers using HA conjugated with various anticancer 
drugs.
Although the exact mechanism for the transdermal 
delivery of HA derivatives is not fully proven yet, there 
are possible reasons and evidences for the trans dermal 
delivery of HA derivatives across the skin barrier. 
First, HA is a hygroscopic polyanion that keeps high 
water content within its structural backbone. The skin 
hydration is important for the enhancement of skin 
permeability. When SC is exposed to water, the tis-
sue swells and forms paths for the molecular transport 
into the skin. HA derivatives can hydrate SC, opening 
penetration routes and facilitating transdermal deliv-
ery of tethered cargos. Along with biocompatibility, 
viscoelasticity and antiwrinkle effect, the ability to 
hydrate the skin has made HA as a unique molecule 
for various cosmetic and cosmeceutical applications.
Second, HA is an amphiphilic liner polysaccharide 
at the molecular level. HA is well known as one of 
the hydrophilic polysaccharides, but structural analy-
sis has revealed at the molecular level that there is a 
hydrophobic patch domain consisting of eight CH 
groups [15]. In addition, NMR and rotary-shadowing 
electron microscopy showed that hydrophobic patch 
domain of HA could make a complex with phos-
pholipids [16,17]. The structural hydrophobic patch 
domain of HA may interact with lipid components 
in SC during penetration and disrupt skin barriers, 
enhancing the skin permeability of HA derivatives. 
Similarly, gold nanoparticle was reported to disrupt 
SC by the interaction of lipid–gold nanoparticle [18]. 
We previously compared the transdermal delivery 
of HA conjugated nanographene oxide (NGO) and 
polyethylene glycol conjugated NGO in normal and 
cancer model mice [9]. While the nonfouling polyeth-
ylene glycol inhibited the skin penetration of NGO in 
both normal and cancer model mice, HA conjugated 
NGO with a dimension of 200 nm appeared to be 
transdermally delivered through the cancerous skin.
Third, HA receptors on skin resident cells facilitate 
the transdermal delivery of HA derivatives. HA recep-
tors are highly expressed in the keratinocytes in epi-
dermis and fibroblasts in dermis. We previously visu-
alized the transdermal delivery of HA–human growth 
hormone (hGH) conjugate in Balb/c mice [11]. After 
topical delivery of HA derivatives, the HA receptor 
mediated internalization into skin cells appeared to 
facilitate the transdermal delivery of HA derivatives, 
forming the concentration gradient from the top to 
the bottom of skin tissues. The bioavailability of 
hGH in the HA–hGH conjugate after transdermal 
delivery was as high as 15%, reflecting the feasibil-
ity of HA as a promising transdermal delivery car-
rier of protein drugs. The transdermal delivery of HA 
derivatives was more efficient in cancerous skin. On 
the surface of skin cancer cells, especially melanoma, 
highly expressed HA receptors can internalize HA 
derivatives via the HA receptor mediated endocyto-
sis. The effective transdermal delivery of HA–NGO 
conjugates for the photothermal ablation therapy of 
skin cancer might be also related with HA receptors 
locally overexpressed around cancerous skin tissues. 
The transdermally delivered HA–NGO accumulated 
specifically in leaky and damaged skin cancer regions, 
and the near-infrared laser irradiation successfully 
ablated the tumor tissues [9].
In summary, with the development of various 
nanoconstructs, their transdermal delivery has been 
actively investigated for facile biomedical applica-
tions. HA could be the key molecule to enhance the 
transdermal penetration of nanoconstructs by the 
synergetic effect of the following factors. The hygro-
scopic HA molecules hydrate skin tissues and open 
the transdermal pathway of conjugated cargos. The 
structural hydrophobic patch domains in HA mol-
ecule help the penetration of HA and its cargo dis-
rupting lipid structure of SC. HA receptors expressed 
on skin cells and highly expressed HA receptors on 
cancerous skin cells can facilitate the continuous pen-
etration of HA derivatives via the HA receptor medi-
ated internalization into the cells. Taken together, HA 
can be used as a promising transdermal delivery car-
rier of nanoconstructs for diagnostic and therapeutic 
applications.
“...hyaluronic acid can be used as a promising 
transdermal delivery carrier of nanoconstructs for 
diagnostic and therapeutic applications.”
future science group
Editorial    Jung, Kim, Yun & Hahn
www.futuremedicine.com 745
Financial & competing interests disclosure
This work was financially  supported by  the Converging Re-
search Center Program through the National Research Foun-
dation of Korea (NRF) funded by the Ministry of Education, 
Science and Technology (2009-0081871). This study was also 
supported  by Mid-career  Researcher  Program  through NRF 
grant  funded  by  the MEST  (No.  2012R1A2A2A06045773). 
The  authors  have  no  other  relevant  affiliations  or  financial 
involvement  with  any  organization  or  entity  with  a  finan-
cial  interest  in  or  financial  conflict with  the  subject matter 
or  materials  discussed  in  the  manuscript  apart  from  those 
disclosed.
No writing assistance was utilized in the production of this 
manuscript.
References
1 Kim BYS, Rutka JT, Chan WCW. Nanomedicine. N. Engl. J. 
Med. 363, 2434–2443 (2010).
2 Schafer-Korting M, Mehnert W, Korting HC. Lipid 
nanoparticles for improved topical application of drugs for 
skin diseases. Adv. Drug Deliv. Rev. 59, 427–443 (2007).
3 Zhang Z, Tsai PC, Ramezanli T et al. Polymeric 
nanoparticles-based topical delivery systems for the treatment 
of dermatological diseases. Wiley Interdiscip. Rev. Nanomed. 
Nanobiotechnol. 5, 205–218 (2013).
4 Nel A, Xia T, Madler L et al. Toxic potential of materials at 
the nanolevel. Science 311, 622–627 (2006).
5 Kumar A, vemula PK, Ajayan PM et al. Silver-nanoparticle-
embedded antimicrobial paints based on vegetable oil. Nat. 
Mater. 7, 236–241 (2008).
6 Larson DR, Zipfel WR, Williams RM et al. Water-soluble 
quantum dots for multiphoton fluorescence imaging in vivo. 
Science 300, 1434–1436 (2003).
7 Kuo TR, Wu CL, Hsu CT et al. Chemical enhancer induced 
changes in the mechanisms of transdermal delivery of zinc 
oxide nanoparticles. Biomaterials 30, 3002–3008 (2009).
8 Lu W, Xiong C, Zhang G et al. Targeted photothermal 
ablation of murine melanomas with melanocyte-stimulating 
hormon analog-conjugated hollow gold nanospheres. Clin. 
Cancer Res. 15, 876–886 (2009).
9 Jung HS, Kong WH, Sung DK et al. Nanographene oxide-
hyaluronic acid conjugate for photothermal ablation therapy 
of skin cancer. ACS Nano 8, 260–268 (2014).
10 Prausnitz MR, Langer R. Transdermal drug delivery. Nat. 
Biotechnol. 26, 1261–1268 (2008).
11 Yang JA, Kim ES, Kwon JH et al. Transdermal delivery 
of hyaluronic acid – human growth hormone conjugate. 
Biomaterials 33, 5947–5954 (2012).
12 Prausnitz MR, Mitragotri S, Langer R. Current status and 
future potential of transdermal drug delivery. Nat. Rev. Drug. 
Discov. 3, 115–124 (2004).
13 Brown TJ, Alcom D, Fraser JR. Absorption of hyaluronan 
applied to the surface of intact skin. J. Invest. Dermatol. 113, 
740–746 (1999).
14 Tian X, Azpurua J, Hine C et al. High-molecular-mass 
hyaluronan mediates the cancer resistance of the naked mole 
rat. Nature 499, 346–349 (2013).
15 Brown MB, Jones SA. Hyaluronic acid: a unique topical 
vehicle for the localized delivery of drugs to the skin. J. Eur. 
Acad. Dermatol. Venerol. 19, 308–318 (2005).
16 Ghosh P, Hutadilok N, Adam N et al. Interactions of 
hyaluronan (hyaluronic acid) with phospholipids as 
determined by gel permeation chromatography, multi-angle 
laser-light-scattering photometry and 1H-NMR spectroscopy. 
Int. J. Biol. Macromol. 16, 237–244 (1994).
17 Pasquali-Ronchetti I, Quaglino D, Mori G et al. 
Hyaluronan–phospholipid interactions. J. Struct. Biol. 120, 
1–10 (1997).
18 Huang Y, Yu F, Park YS et al. Co-administration of protein 
drugs with gold nanoparticles to enable percutaneous 
delivery. Biomaterials 31, 9086–9091 (2010).
future science group
Enhancing the transdermal penetration of nanoconstructs: could hyaluronic acid be the key?    Editorial
